Filter
1999
Filtered Results: 1999
Text search:
drug
regimens
Featured
Recommendations
206
New Publications
527
Language
Document type
No document type
1285
Guidelines
285
Studies & Reports
247
Manuals
62
Strategic & Response Plan
38
Fact sheets
35
Training Material
25
Situation Updates
7
Infographics
7
Resource Platforms
4
Brochures
2
Online Courses
2
Countries / Regions
India
120
South Africa
64
Kenya
52
Global
49
Ethiopia
48
Tanzania
47
Western and Central Europe
42
Uganda
37
Nigeria
36
Zambia
34
Nepal
31
Eastern Europe
31
Rwanda
28
Africa
25
Latin America and the Carribbean
25
Malawi
24
Ghana
22
Ukraine
21
Liberia
20
Philippines
18
Bangladesh
18
Namibia
18
Myanmar / Burma
18
Asia
17
Zimbabwe
16
Cambodia
14
Sierra Leone
13
Mozambique
12
South–East Asia Region
12
Russia
12
Lesotho
11
Indonesia
11
Botswana
10
Eswatini/ Swaziland
8
Colombia
7
Thailand
7
Cameroon
7
Senegal
7
Congo, Democratic Republic of
6
Brazil
6
Albania
5
Haiti
5
Georgia
5
Tajikistan
4
Syria
4
USA
4
Venezuela
4
West and Central Africa
4
East and Southern Africa
4
Argentina
4
Pakistan
4
Benin
3
China
3
Estonia
3
Germany
3
Western Pacific Region
3
Jamaica
3
Vietnam
3
Bhutan
3
South Sudan
3
Timor Leste/ East Timor
2
Burkina Faso
2
Afghanistan
2
Eastern Europe and Central Asia
2
Paraguay
2
North America
2
Sri Lanka
2
Sudan
2
Romania
2
Iraq
2
Somalia
2
North Macedonia
1
North Korea
1
El Salvador
1
Gambia
1
Chile
1
Iran
1
Fiji
1
Laos
1
Peru
1
Morocco
1
Guinea
1
Jordan
1
Saudi Arabia
1
Middle East and North Africa
1
Denmark
1
Tunisia
1
United Kingdom
1
Côte d’Ivoire / Ivory Coast
1
Bolivia
1
Lebanon
1
Papua New Guinea
1
Greece
1
Central African Republic
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
718
Clinical Guidelines
282
Public Health
86
Women & Child Health
70
Capacity Building
41
Key Resources
27
Pharmacy & Technologies
18
Toolboxes
TB
377
HIV
352
NTDs
91
AMR
78
Pharmacy
60
Mental Health
48
COVID-19
45
NCDs
45
Ebola & Marburg
29
Refugee
23
Caregiver
23
Rapid Response
16
Conflict
16
Polio
11
Disability
9
Health Financing Toolbox
7
Specific Hazards
4
Natural Hazards
4
Planetary Health
4
Malaria
4
Global Health Education
4
Cholera
3
Social Ethics
3
Zika
1
Reporting system for the general public - This document aims to provide practical guidelines on how to set up national systems for consumers to report adverse reactions to medicines. The purpose is to help countries set up a well-organized and effective consumer reporting system within their pharmac...
This course will provide you with the knowledge and skills needed to implement WHO-recommended TB tests and algorithms. It includes the latest recommendations for novel tests for TB diagnosis and detection of drug resistance, as well as the most recent WHO policy guidance for the use of those tests....
N Engl J Med 2022; 386:911-922, DOI: 10.1056/NEJMoa2104535
Four months of antituberculosis treatment was noninferior to 6 months of treatment in children with drug-susceptible, nonsevere, smear-negative tuberculosis (SHINE Study)
Patients with retreatment tuberculosis (TB) represent those
who have been treated previously for onemonth ormorewith
anti-TB drugs and who have been diagnosed once again with
the disease.These patientsmainly include relapses, treatment
after failure, or loss to follow-up on a first-line treatmen...
Tuberculosis treatment failure results in increased risk of morbidity, drug resistance, transmission and mortality. There are few data about tuberculosis treatment outcomes in Burkina Faso. The current study investigated the factors associated with tuberculosis treatment failure in the central east ...
Lymphatic filariasis is a neglected tropical disease that can cause permanent disability through disruption of the lymphatic system. This disease is caused by parasitic filarial worms that are transmitted by mosquitos. Mass drug administration (MDA) of antihelmintics is recommended by WHO to elimina...
We systematically reviewed Medline as well as the references of published review articles for relevant studies of adherence to multidrug treatment of both drug-susceptible and drug-resistant TB through February 3, 2018. We included randomized controlled trials (RCTs) as well as prospective and retro...
1PEP GUIDELINES | 2019 EDITION. The prevalence of both HIV and Hepatitis B is high in South Africa therefore there is a significant risk of acquiring these infections following exposure to infected material. Studies suggest that post- exposure prophylaxis (PEP) with highly active antiretroviral trea...
The 7th edition of the Orange Guide provides practical guidance to health workers on the front line of TB control. It includes sections on HIV, MDR-TB and a review of the recommended treatment regimens
This guide is a resource for physicians and other health care professionals who provide care and treatment to patients with drug-resistant tuberculosis.
The WHO South-East Asia (SEA) Region bears a high burden of tuberculosis (TB) and MDR-TB. In 2015, the Region accounted for nearly 200 000 or 35% of the global estimated new RR/MDR-TB cases eligible for treatment. Extensively drug-resistant TB (XDRTB) has also been reported from s...
The Pharmacovigilance team in WHO aims to assure the safety of medicines and vaccines by ensuring reliable and timely exchange of information on safety issues, promoting pharmacovigilance activities throughout the Organization and encouraging participation in the WHO Programme for International Drug...
Following the encouraging initial results of the pilot project, the Ministry of Health is committed to increasing access to MDR-TB diagnosis, treatment and care. An expansion plan for the programmatic management of drug-resistant TB has been developed and forms part of the Five Year National Strateg...
The Updated guidelines on Management of tuberculosis in children and adolescents include new recommendations that cover diagnostic approaches for TB, shorter treatment for children with non-severe drug-susceptible TB, a new option for the treatment of TB meningitis, the use of bedaquiline and delama...
This chapter discusses the antibacterial treatment of leprosy infections. Antibiotic treatment is
a key component of leprosy treatment, as it is vital to prevent the progression of the infection.
Treatment with rifampin and other antibiotics is highly effective and cures 98% of patients with
the ...
Version 10.1_5 October 2020
These Guidelines are available in different formats: As a paper booklet, a PDF, a mobile app, and now also as a website.
The 2019 version of the Guidelines introduces a new drug-drug interaction panel and now consists of six main sections, including a general overview ...
The purpose of this manual is to define a limited number of indicators that will objectively describe the management and use of antimicrobials in hospitals and to provide tools and step-by-step instructions for designing and carrying out an assessment of antibiotic use and management in hospitals. T...
This manual summarizes key issues related to the safety of NTD medicines and their administration, with a focus on essential medicines used in mass drug administration (MDA), also called preventive chemotherapy. It can be used as a standalone reference manual, but is intended to be used in conjuncti...
The Global Programme on Tuberculosis & Lung Health of the World Health Organization (WHO/GTB) is now combining all current recommendations into one overall set of consolidated guidelines on TB. The guidelines contain recommendations pertaining to all areas related to the programmatic management of T...
The main objective of these guidelines is to provide guidance on up-to-date, uniform, evidence-informed practices for suspecting, diagnosing and managing various forms of extra-pulmonary tuberculosis (EPTB) at all levels of healthcare delivery. They can then contribute to the National Programme to i...
